Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Ependymoma 1Craniopharyngioma 1

Interventions

Cyclophosphamide 9Melphalan 8X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 7Busulfan 7Flow Cytometry 6Filgrastim 6Nuclear Medicine Department, Hospital 5Methylprednisolone 5Carboplatin 5Biopsy 5Therapeutics 4Radiotherapy 4Psychiatric Rehabilitation 4Ipilimumab 4Etoposide 4Antilymphocyte Serum 4Alemtuzumab 4fludarabine 3Topotecan 3Thiotepa 3Stem Cell Transplantation 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Immunologic Techniques 3Crizotinib 3Caspofungin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Methionine × Lymphoid × Clear all
NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡